Sponsor of the Day:
Jerkmate
https://www.news-medical.net/industry-focus/Event-guide-The-Non-Opioid-Pain-Therapeutics-Summit
Event guide: The Non-Opioid Pain Therapeutics Summit | eBook
Explore how the Non-Opioid Pain Therapeutics Summit is accelerating the industry’s next big leap in pain management.
non opioid painevent guidetherapeutics summitebook
https://news.hss.edu/hss-study-evaluates-non-opioid-pain-relief-following-orthopedic-surgery/
HSS Study Evaluates Non-Opioid Pain Relief Following Orthopedic Surgery
Apr 16, 2026 - A retrospective study presented at the 51st Annual Regional Anesthesiology and Acute Pain Medicine Meeting by investigators at Hospital for Special Surgery...
non opioid painorthopedic surgeryhssstudyevaluates
https://www.abbott.com/en-us/corpnewsroom/pain-and-movement/for-chronic-pain--a-non-opioid-alternative
For Chronic Pain, a Non-Opioid Alternative
Neurostimulation is a drug-free option for chronic pain management. Learn more about the therapy and how you can reduce medications and limit side effects.
chronic painnon opioidalternative
https://www.fda.gov/news-events/press-announcements/fda-approves-novel-non-opioid-treatment-moderate-severe-acute-pain
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain | FDA
The FDA approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic to treat moderate to severe acute pain in adults.
fda approvesnon opioidsevere acutenoveltreatment
https://news.stonybrook.edu/university/non-opioid-pain-therapy-discovered-at-stony-brook-advances-with-11-million-private-investment/
Non-Opioid Pain Therapy Discovered at SBU Receives $11M Investment
Apr 2, 2026 - A novel, non-opioid pain drug candidate originating from research at the State University of New York at Stony Brook has reached a significant milestone.
non opioid paintherapydiscoveredsbureceives